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ABSTRACT
Introduction: The prevention strategies for MTCT of HIV proposed by the World Health 
Organization (WHO) and other agencies have significantly reduced the number of 
infected children, child morbidity and mortality associated with HIV, and have improved 
maternal health. However, the detection rate of pregnant women with HIV in Brazil 
significantly increased in the last decade10.
Objective: To evaluate factors that may interfere in mother-to-child transmission 
(MTCT) of human immunodeficiency virus (HIV).
Methods: A historical cohort study with a sample of 299 HIV-infected mothers and 
their newborns who delivered at the Obstetric Center of the Hospital de Clínicas de 
Porto Alegre, southern Brazil, from January 2010 to December 2014.
Results: Of the 299 newborns of HIV-infected mothers, 3.7% (n = 11) were infected. Of 
those, 90.9% (n = 10) were born by cesarean section; 90.9% (n = 10) had ≥ 37 weeks; 
54.6% (n = 6) received zidovudine starting within the first 4 hours after birth; and 
45.4% (n = 5) received zidovudine and nevirapine. Four women whose newborns 
were infected with HIV had syphilis during pregnancy (36.4%). Poor adherence to 
highly active antiretroviral therapy (HAART) (p < 0.003), viral load ≥ 1000 copies/mL 
or ignored in the third trimester (p < 0.000), and CD4 count < 500 cells/mm3 in the third 
trimester (p < 0.046) were significantly associated with an increased risk of MTCT.
Conclusions: Lack of control of risk factors may contribute to unfavorable rates of 
MTCT of HIV.
Keywords: Risk factors; infectious disease transmission; vertical transmission; 
acquired immunodeficiency syndrome
In the absence of a preventive intervention, the risk of human immunodeficiency 
virus (HIV) transmission in utero or during delivery is 15 to 30%, increasing to 
24 to 42% through breastfeeding1. In 1994, Connor et al.2 demonstrated that 
a regimen of zidovudine (ZDV) reduced risk of mother-to-child transmission 
(MTCT) of HIV of 67.5%. Subsequently, several studies have shown that 
combination therapy during pregnancy, cesarean section (indicated when 
maternal viral load after 34 weeks ≥ 1000 copies/mL), and interruption of 
breastfeeding reduce the rate of MTCT of HIV to less than 2%3-7. Despite 
the implementation of these measures, MTCT of HIV remains a challenge 
to global public health7.
The prevention strategies for MTCT of HIV proposed by the World Health 
Organization (WHO) and other agencies have significantly reduced the 
number of infected children, child morbidity and mortality associated with 
HIV, and have improved maternal health8,9. However, the detection rate of 
pregnant women with HIV in Brazil significantly increased in the last decade10. 
In 2006, the rate was 2.1 cases per 1,000 live births, rising to 2.7 in 2015, 
an increase of 28.6%. The southern region has the highest detection rate, 
approximately 2.2 times higher than the average rate in Brazil10.
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The state of Rio Grande do Sul is at the top of 
the national ranking with an HIV detection rate of 
10.1 cases per 1,000 live births, as reported in the 
notifiable diseases information system (Sinan). Porto 
Alegre was the capital with the highest detection 
rate in 2015, with 22.9 cases per 1,000 live births10.
This study aimed to analyze risk factors associated 
with MTCT of HIV in order to contribute to the 
improvement of actions that seek to reduce the 
transmission rate in the city of Porto Alegre.
METHODS
A retrospective cohort study of HIV-positive mothers 
and their newborns whose delivery occurred in the 
Obstetric Center of the Hospital de Clínicas de Porto 
Alegre (HCPA) from January 2010 to December 2014. 
Data collection was conducted between June and 
October 2015 based on medical records. This study 
was approved by the Ethics Committee of the HCPA 
(protocol no. 140568).
The study included 323 women initially, but the 
following were excluded: five women whose confirmatory 
HIV test, after the rapid test, was negative, 17 women 
whose children were followed in another city, and 
two women who had stillbirths and did not undergo 
serologic testing for HIV.
Women’s identification data were collected such 
as age, color, nationality, marital status and level of 
education.
The following variables were analyzed: use of 
highly active antiretroviral therapy (HAART), therapy 
adherence, sexually transmitted diseases, smoking, 
drugs, prenatal care, quantification of viral load and 
T-cell count (CD4 count), mode of delivery, time of 
the rupture of membranes, birth weight, gestational 
age, Apgar score, and lactation.
HAART adherence was considered good when 
HIV-positive women took at least 95% of prescription 
drugs (40), an amount that ensures the inhibition 
of HIV replication. The frequency of withdrawal of 
medications at the pharmacy and the maternal viral 
load measured by laboratory tests were considered 
parameters for good or bad adherence11.
Regarding mode of delivery, the Obstetric Center 
of HCPA follows the current guidelines of the Brazilian 
Ministry of Health, which states that when the maternal 
viral load after 34 weeks is < 1000 copies/mL, vaginal 
delivery is recommended, preferably without amniotomy, 
episiotomy, or instrumentation, according to obstetric 
conditions. However, when the maternal viral load 
after 34 weeks is ≥ 1000 copies/mL or unknown, 
elective cesarean section is recommended after the 
38th week of gestation11.
Breastfeeding is contraindicated in HIV-positive 
women, as well as cross-lactation (another nursing 
mother breastfeeding the child), mixed feeding 
(breast milk and infant milk formula), and use of 
human milk with home pasteurization. In the present 
study, all children received infant milk formula 
until 6 months of age11.
As recommended by the Brazilian Ministry of 
Health, zidovudine (ZDV) syrup should be used for 
four weeks (28 days) after birth11. Newborns started 
receiving ZDV syrup in the delivery room, immediately 
after birth11. An oral suspension form of nevirapine in 
combination with ZDV was administered to newborns 
whose mothers were diagnosed with HIV at delivery, 
did not use HAART during prenatal care, had a 
viral load > 1000 copies/mL in the last trimester of 
pregnancy, or with syphilis during pregnancy12.
The children were followed at an outpatient clinic 
until the definition of their HIV status. In our study, 
children were considered non-infected when they had 
two viral load tests with undetectable results and/or 
HIV tests (enzyme-linked immunosorbent assay, 
ELISA) with non-reactive results after 18 months11.
Statistical analysis was performed using SPSS 
statistical software, version 18.0. In all analyses, a 
p-value ≤ 0.05 was considered statistically significant. 
Anonymity and privacy of patients, according to the 
recommendations of the Guidelines and Regulatory 
Norms Involving Human Subjects of the Brazilian 
National Health Council Resolution no. 466/12, were 
guaranteed.
RESULTS
From January 2010 to December 2014, 299 mothers 
whose infants borned at the Obstetric Center of HCPA, 
were followed to confirm or exclude the diagnosis 
of HIV. The MTCT rate during the study period 
was 3.7% – 11 cases in 299 live births (Table 1).
The epidemiological characteristics of the 
HIV-positive women included in the study are described 
in Table 2. There was a predominance of mothers 
aged 21 to 39 years (81.8%, n = 9), of black color 
(63.6%, n = 7), married (90.9%, n = 10), from Porto 
Alegre (81.8%, n = 9), and all of them were Brazilians. 
Regarding level of education, only 9.1% (n = 1) 
had higher education. Among the mothers whose 
newborns were infected with HIV, 54.6% (n = 6) 
had less than six prenatal care visits, and 90.9% 
(n= 10) showed rupture of membranes < 4 hours 
and gestational age ≥ 37 weeks (Table 3).
Table 1: Prevalence of mother-to-child HIV transmission at a 
university hospital in Porto Alegre, Brazil, from 2010 to 2014.
Total Newborns infected with HIV
Newborns not 
infected with HIV
n % n % n %
299 100.0 11 3.7 288 96.3
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Table 2: Sociodemographic characteristics of HIV-positive mothers at a university hospital in Porto Alegre, Brazil, from 
2010 to 2014.
Children infected with 
HIV
(n = 11)




(n = 299) p-value
n % n % n %
Age
≤ 20 years 2 18.2 36 12.5 38 12.7 0.792*
21-39 years 9 81.8 238 82.6 247 82.6
≥ 40 years 0 0.0 14 4.9 14 4.7
Total 11 100.0 288 100.0 299 100.0
Color
White 3 27.3 193 67.0 196 65.6 0.003**
Brown 1 9.1 37 12.8 38 12.7
Black 7 63.6 58 20.2 65 21.7
Total 11 100.0 288 100.0 299 100.0
Level of 
education
Middle school§ 5 45.4 155 53.8 160 53.5 0.749**
High school§§ 5 45.4 99 34.4 104 34.8
Higher education§§§ 1 9.2 34 11.8 35 11.7
Total 11 100.0 288 100.0 299 100.0
Marital status
With a partner 10 90.9 275 95.5 285 95.3 0.497**
Without a partner 1 9.1 13 4.5 14 4.7
Place of birth
Porto Alegre 9 81.8 196 68.5 205 69.0 0.547**
Countryside 2 18.2 90 31.5 92 31.0
Total 11 100.0 286 100.0 297 100.0
*Fisher’s exact test; **Pearson’s chi-square test; §Middle school incomplete and complete; §§High school incomplete and complete; §§§Higher 
education incomplete and complete.
Table 3: Risks to mother-to-child HIV transmission associated with maternal exposure and therapy adherence.
Newborns infected with 
HIV (n = 11)
Newborns not infected 
with HIV (n = 288)
Total
(n = 299) p-value
n % n % n %
No. of prenatal visits
≤ 1 visit 2 18.2 32 11.1 34 11.4 0.669**
2-5 visits 4 36.4 91 31.6 95 31.7
≥ 6 visits 5 45.4 165 57.3 170 56.9
Total 11 100.0 288 100.0 299 100.0
Rupture of 
membranes
< 4 hours 10 90.9 230 80.0 240 80.3 0.659**
≥ 4 hours 1 9.1 56 19.4 57 19.1
Unknown 0 0.0 2 0.6 2 0.6
Total 11 100.0 288 100.0 299 100.0
Mode of delivery
Cesarean section 10 90.9 183 63.5 193 64.5 0.063**
Vaginal delivery 1 9.1 105 36.5 106 35.5
Total 11 100.0 288 100.0 299 100.0
Gestational age
< 37 weeks 1 9.1 71 24.7 72 24.1 0.409**
≥ 37 weeks 10 90.9 217 75.3 227 75.9
Total 11 100.0 288 100.0 299 100.0 
**Pearson’s chi-square test.
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An undetectable HIV viral load in the third trimester 
(47.8%, n = 143) and a CD4 count ≥ 500 cells/mm3 
(43.2%, n = 126) (p < 0.046) significantly reduced 
MTCT of HIV, as well as good adherence to HAART 
(52.5%, n = 157) (p < 0.003) and use of the full scheme 
for MTCT prevention (90.4%, n = 264) (p < 0.002). 
We found that 36.4% (n = 4) of the women whose 
newborns were infected with HIV did not use HAART 
during prenatal care because they were diagnosed 
with HIV only at delivery through rapid testing. 
Furthermore, 36.4% (n = 4) women presented reactive 
VDRL results (p < 0.013), 63.6% (n = 7) had a HIV 
viral load ≥ 1000 copies/mL in the third trimester 
(p < 0.001), and none of them had an undetectable 
HIV viral load. Four women were diagnosed with HIV 
at birth and had no viral load (Table 4).








(n = 299) p-value
n % n % n %
CD4 count – third 
trimester
< 500 cells/mm3 8 72.7 111 38.5 119 39.8 0.046**
≥ 500 cells/mm3 3 27.3 124 43.1 127 42.5
Ignored 0 0.0 53 18.4 53 17.7
Total 11 100.0 288 100.0 299 100.0
Viral load – third 
trimester
Undetectable 0 0.0 143 49.7 143 47.8 0.001**
< 1000 copies/mL 4 36.4 51 17.7 55 18.4
≥ 1000 copies/mL 7 63.6 52 18.0 59 19.7
Ignored 0 0.0 42 14.6 42 14.1
Total 11 100.0 288 100.0 299 100.0
Maternal HAART
Complete 7 63.6 263 91.3 270 90.3 0.002**
Incomplete§ 4 36.4 25 8.7 29 9.7
Total 11 100.0 288 100.0 299 100.0
HAART adherence
Good 1 9.1 157 54.5 158 52.8 0.003**
Bad 10 90.9 131 45.5 141 47.2
Total 11 100.0 288 100.0 299 100.0
IV ZDV during labor
Yes 7 63.6 239 83.0 246 82.3 0.099**
No 4 36.4 49 17.0 53 17.7
Total 11 100.0 288 100.0 299 100.0
VDRL test
Reactive 4 36.4 32 11.1 36 12.0 0.012**
Non-reactive 7 63.6 256 88.9 263 88.0
Total 11 100.0 288 100.0 299 100.0 
**Pearson’s chi-square test; §Highly active antiretroviral therapy (HAART) was considered incomplete when pregnant women did not use 
it during prenatal care. They were diagnosed with HIV only after a rapid test in the delivery room. IV ZDV, intravenous zidovudine; VDRL, 
Venereal Disease Research Laboratory.
Regarding the characteristics of the 
HIV-infected newborns associated with MTCT 
(3.7%, n = 11), 63.6% (n = 7) were female, 81.8% 
(n = 9) weighed ≥ 2500 grams, 72.7% (n = 8) had 
appropriate gestational age, and 100.0% (n = 11) 
did not require intubation (Table 5). There was no 
statistically significant difference.
All newborns (100.0%, n = 299) received either 
ZDV orally (81.9%, n = 245) or ZDV and nevirapine 
(18.1%, n = 54) orally starting within the first 4 hours 
of life and lasting for four weeks13. Only one 
uninfected newborn was breastfed, although all 
mothers were instructed not to breastfeed, and all 
newborns received infant milk formula until they 
completed six months.
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DISCUSSION
In the present study, the rate of MTCT of HIV 
was 3.7%, almost twice as the target (2%) set by the 
Regional Validation Committee for the elimination 
of MTCT of HIV and congenital syphilis, created by 
the Pan American Health Organization (PAHO), of 
which Brazil is a participating country8. There have 
been many efforts to reduce MTCT of HIV11 in Brazil. 
However, according to our study, low adherence to 
HAART was significantly related to increase MTCT11.
A higher prevalence of HIV-positive newborns 
of mothers with lower levels of education has been 
found, which could mean that they are less aware 
of the importance of adherence to HAART and 
prenatal care. We found a significant association 
between HIV-positive newborns and self-declared 
black mothers11.
WHO estimates that more than 2 million pregnant 
women are infected with syphilis and HIV per year 
worldwide. Syphilis during pregnancy is associated 
with an increased risk for MTCT. Our study found 
that 36.4% (4/11) mothers with syphilis had children 
infected with HIV (p < 0.013)8,12.
For those women who did not receive prenatal care 
and had no previous diagnosis of HIV, rapid testing 
allowed the adoption of measures to prevent MTCT. 
Although these measures have been implemented, 
36.4% of women with HIV-infected newborns were 
diagnosed with HIV in the delivery room. Thus, incomplete 
prophylaxis scheme was significantly associated with 
increased MTCT (p < 0.002).
Controlling viral factors is important to decrease 
the rate of MTCT of HIV. In our study, poor adherence 
to HAART (p < 0.003), viral load ≥ 1000 copies/mL 
or ignored in the third trimester (p < 0.001), and CD4 
count < 500 cells/mm3 (p < 0.046) in the third trimester 
were significantly related to increased MTCT14,15. 
Evidently, better results will only be achieved with 
early diagnosis of HIV, careful monitoring, and 
adherence to prenatal care. The lack of detection 
of HIV infection during prenatal care represents a 
wasted opportunity to prevent MTCT. Appropriate 
prenatal care helps HIV-positive pregnant women 
understand their disease, improves adherence to 
the recommendations of health professionals, and 
facilitates the identification and treatment of diseases 
Table 5: Newborn characteristics associated with mother-to-child HIV transmission at a university hospital in Porto Alegre, 
Brazil, from 2010 to 2014.
Newborns infected with 
HIV (n = 11)
Newborns not infected 
with HIV (n = 288)
Total
(n = 299) p-value
n % n % n %
Sex
Female 7 63.6 137 47.6 144 48.2 0.460**
Male 4 36.4 151 52.4 155 51.8
Total 11 100.0 288 100.0 299 100.0
Weight
< 2500 grams 2 18.2 59 20.5 61 20.4 0.999**
≥ 2500 grams 9 81.8 229 79.5 238 79.6
Total 11 100.0 288 100.0 299 100.0
Gestational 
adequacy
Adequate 8 72.7 203 70.4 211 70.6 0.855**
Excessive 0 0.0 8 2.8 8 2.7
Inadequate 3 27.3 77 26.8 80 26.7
Total 11 100.0 288 100.0 299 100.0
Intubation
Intubated 0 0.0 14 4.9 14 4.7 0.983**
Non-intubated 11 100.0 274 95.1 285 95.3
Total 11 100.0 288 100.0 299 100.0
Antiretroviral 
therapy
ZDV 6 54.5 239 83.0 245 81.9 0.031*
ZDV + NVP 5 45.5 49 17.0 54 18.1
Total 11 100.0 288 100.0 299 100.0
*Fisher’s exact test; **Pearson’s chi-square test. NVP, nevirapine; ZDV, zidovudine.
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that increase MTCT, such as syphilis. The rate of MTCT 
of HIV will be similar to that of developed countries 
when all HIV-positive pregnant women have access 
and adhere to prenatal care and HAART.
Although this study had limitations due to its 
retrospective design, we obtained important information 
to improve prenatal monitoring and MTCT control. 
The use of illicit drugs may have not been identified 
in those patients who did not receive appropriate 
prenatal care. This could influence the effect of HAART 
and, consequently, the control of the viral parameters 
that affect MTCT. This is one of our challenges to 
avoid MTCT of HIV. Lack of control of risk factors 
may contribute to unfavorable rates of MTCT of HIV.
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